Anthropometric data | Comorbidities | ||
---|---|---|---|
Ethnicity | CKD | 3 (8.1%) | |
 Caucasian | 35 (94.6%) | CLD (Child-Pugh ≥ B) | 1 (2.7%) |
 Asian | 2 (5.4%) | Diabetes | 8 (21.6%) |
Gender | Previous oncological disease | 3 (8.1%) | |
 Male | 31 (83.8%) | Hypertension | 11 (29.7%) |
 Female | 6 (16.2%) | Cerebral vascular disease | 1 (2.7%) |
 M/F | 31/6 | Coronary vascular disease | 1 (2.7%) |
Age (years) | 59.5 ± 9.5 | Systemic vascular disease | 1 (2.7%) |
Weight (Kg) | 90 ± 19 | Chronic steroid tt | 1 (2.7%) |
Height (cm) | 171 ± 8 | Obesity | 20 (54.1%) |
BMI | 30.3 (5.7) | Other | 13 (35.1%) |
Clinical data at RRT initiation | |||
GCS | Lactates (mmol/L) | 1.67 (1.2) | |
 3 | 36 (97.3%) | Sodium (mmol/L) | 138 (10) |
 4 | 1 (2.7%) | Potassium (mmol/L) | 4.4 ± 0.7 |
Heart rate (bpm) | 91 ± 21 | Magnesium (mg/dL) | 2.3 ± 0.7 |
Rhythm | Phosphate (mg/dL) | 4.7 ± 1.8 | |
 Rhythmic | 31 (83.8%) | Bicarbonate (mEq/L) | 23 ± 5 |
 Arrhythmic | 6 (16.2%) | Hematocrit (%) | 33.8 ± 7.4 |
Systolic pressure (mmHg) | 120 (30) | Baseline creatinine (mg/dL) | 0.89 (0.2) |
Diastolic pressure (mmHg) | 63 ± 12 | Current creatinine (mg/dL) | 2.26 (2.5) |
Mean pressure (mmHg) | 84 (23) | Urinary output (ml/h) | 30 (40) |
Vasoactive | 24 (64.9%) | 24 h urinary output (ml) | 1000 (1250) |
 Adrenaline | 2 (5.4%), 0.03 ± 0.01 μg/kg/min | Urea (mg/dL) | 71 (139) |
 Noradrenaline | 24 (64.9%), 0.20 ± 0.19 μg/kg/min | Bilirubin (mg/dl) | 0.8 (2.5) |
 Vasopressin | 1 (2.7%), 1.6 U/h | Albumin (g/dl) | 2.64 (0.42) |
 Dobutamine | 1 (2.7%), 8 μg/kg/min | Platelets (10^3/μl) | 231 (177) |
 Dopamine | 1 (2.7%), 3 μg/kg/min | INR | 1.1 (0.3) |
Vasoactive Inotropic Score (VIS) | 10 (22) | Antithrombin (%) | 71 ± 26 |
VT settings (ml) | 459 ± 63 | Fibrinogen (mg/dl) | 640 (229) |
 RR (breaths/min) | 23 ± 4 | D-dimers (ng/ml) | 3240 (8417) |
 PEEP (cmH2O) | 13 ± 3 | PCT (ng/ml) | 0.78 (2.59) |
PIP (cmH2O) | 30 (9) | Temp (°C) | 36.7 ± 0.9 |
Mean airway pressure (cmH2O) | 30 | CRP (mg/L) | 200 (176) |
PPlat (cmH2O) | 26 ± 3 | WBC (10^3/μl) | 10.47 (6.73) |
Compliance | 39 ± 12 | Ferritin (ng/ml) | 12.3 ± 5.9 |
FiO2 (%) | 70 (19) | IL-6 (ng/l) | 1230 (895) |
PaO2 | 83 ± 23 | CD 4+ | 164.9 ± 122.5 |
PaO2/FiO2 | 119 ± 42 | Crystalloid prev.12 h (ml) | 906 ± 693 |
SaO2 (%) | 95 (3) | APACHE IV | 117 ± 20 |
PaCO2 (mmHg) | 51 ± 11 | Predicted mortality (%) | 64.7 ± 16.2 |
A-a O2 gradient | 377.7 ± 113.1 | Total SOFA Score | 13 (6) |
pH | 7.31 ± 0.10 |  |  |